Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Haemophilia
; 28(4): 548-556, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35475308
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Proteins
/
Factor VIIa
/
Hemophilia A
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Haemophilia
Journal subject:
HEMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
United States